Sensex Today | Stock Market LIVE Updates: The benchmark indices extended their winning streak for the fourth consecutive session on Thursday, marking the longest rally in nearly two months. The Sensex gained 899 points to close at 76,348, while the Nifty advanced 283 points to settle at 23,191, reaching its highest level since February 13. […]
Sensex Today | Stock Market LIVE Updates: Sensex, Nifty 50 set for gap-up start after US indices rally on Fed decision
Sensex Today | Stock Market LIVE Updates: The equity benchmarks extended gains for the third consecutive session on Wednesday (March 19), with the Nifty closing 73 points higher at 22,908 and the Sensex rising 148 points to 75,449. The broader market outperformed significantly, as the Nifty Midcap index jumped 2.6% (1,300 points) to 50,817, outpacing […]
Sensex Today | Stock Market LIVE Updates: Nifty 50, Sensex likely to open in green; Muthoot Finance in focus
Sensex Today | Stock Market LIVE Updates: Indian benchmark indices Nifty 50 and Sensex ended the previous trade session in the green. Nifty 50 closed at 22,834.30, while Sensex ended at 75,301.26. Sensex Today | Stock Market LIVE Updates: Nifty 50 ended the previous trade session 3,443.05 points away from its record high of 26,277.35. […]
Dr Reddy’s recalls epilepsy drug in US over mislabeling concerns – CNBC TV18
Dr Reddy’s Laboratories has announced a nationwide recall of one batch of Levetiracetam in 0.75% Sodium Chloride Injection (1,000 mg/100 mL) in the US due to a labeling error on the infusion bag. The recall, which applies to lot number A1540076, was initiated after the infusion bag was incorrectly labeled as Levetiracetam in 0.82% Sodium […]
Dr Reddy’s sells 14-drug portfolio to Senores Pharma for US market expansion – CNBC TV18
Dr Reddy’s Laboratories Ltd has entered into an agreement with Ahmedabad-based Senores Pharmaceuticals Ltd to sell a portfolio of 14 Abbreviated New Drug Applications (ANDAs) for an undisclosed amount, Senores Pharma said in a press release on Tuesday. The acquired portfolio consists of 13 ANDAs already approved by the US Food and Drug Administration (FDA) […]
Sensex Today | Stock Market LIVE Updates: Nifty set for its worst monthly losing streak in 28 years; 22,500 remains key
Sensex Today | Stock Market LIVE Updates: Indian benchmark indices Nifty 50 and Sensex ended the previous trade session mixed. Nifty 50 closed at 22,547.55, while Sensex ended at 74,602.12. Sensex Today | Stock Market LIVE Updates: Nifty 50 ended the previous trade session 3,729.8 points below its record high of 26,277.35. Overnight, Wall Street indices […]
Sensex Today | Stock Market LIVE Updates: GIFT Nifty indicates a start in the red for Sensex, Nifty 50
Sensex Today | Stock Market LIVE Updates: The markets delivered negative returns for the third consecutive week on Friday, a trend last seen three months ago. The midcap index gave up Thursday’s gains today, dropping 836 points to 53,263, and the Nifty Bank index ended 221 points lower at 48,368. Sensex Today | Stock Market […]
Dr Reddy’s plans to launch 15-20 products every year – CNBC TV18
Dr Reddy’s Laboratories (DRL), plans to launch 15 to 20 products each year to maintain its market presence, CEO Erez Israeli said. Despite challenges with certain products, Israeli believes that the overall performance will stabilise. The company’s North American revenue declined by over 9%, driven primarily by a reduction in revenues from Revlimid, as its […]
Sensex Today | Stock Market LIVE Updates: Nifty, Sensex set to open higher; Laurus Labs, Shriram Finance Q3 results today
Sensex Today | Stock Market LIVE Updates: Indian benchmark indices Nifty 50 and Sensex ended the previous trade session higher. Nifty 50 closed at 23,205.35, while Sensex ended at 76,520.38. Sensex Today | Stock Market LIVE Updates: Nifty 50 ended the previous trade session 3,072 points away from its record high of 26,277.35. Overnight, Wall […]
Stocks to Watch on January 24: Indus Towers, HPCL, Dr Reddy’s, Mphasis and more – CNBC TV18
1 / 19 Indus Towers | The company’s third-quarter consolidated net profit (PAT) surged to ₹4,003.2 crore, marking a substantial nearly 160% increase from ₹1,540.5 crore in the same period last year. This performance was bolstered by significant overdue collections from a major customer, leading to a ₹3,024 crore write-back of doubtful receivables. The company’s […]